Annual report
4350.TEDINET S100R0WL
Period2022-04-01 → 2023-03-31
Filed2023-06-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥109.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥106.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥104.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥105.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.9bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥895m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥462m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥66.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥62.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥64.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥66.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥68.9bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥51.7bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥49.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.2bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥9.4bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.8bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥53.38 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.35 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.51 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-29.48 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.25 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.04 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥478.86 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.67 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥370.23 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥310.39 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥354.77 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 21.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.2% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,619 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,514 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 3,326 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,205 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 3,076 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥7.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥6.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥429m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥404m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥902m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.1bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥53.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥53.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥54.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥57.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥57.0bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥37.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥14.6bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥71.75 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.89 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.01 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.74 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.82 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥47.64 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.65 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥12 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥606.46 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥547.69 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥483.95 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥450.36 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥416.39 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 34.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 30,642,600 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 354 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 337 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 285 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 262 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 257 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Otherother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥1m |
| Otherother segments | employees | at 2023-03-31 | 38 pure |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥304m |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥304m |
| Otherother segments | segment assets | at 2023-03-31 | ¥63m |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥22m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥247m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥128m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥937m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥937m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥2.5bn |
| Community Pharmacy Network Segmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥4.6bn |
| Community Pharmacy Network Segmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Community Pharmacy Network Segmentreportable segment | employees | at 2023-03-31 | 3145 pure |
| Community Pharmacy Network Segmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥104.4bn |
| Community Pharmacy Network Segmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥104.4bn |
| Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥32m |
| Community Pharmacy Network Segmentreportable segment | segment assets | at 2023-03-31 | ¥46.1bn |
| Community Pharmacy Network Segmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥5.9bn |
| Lunch Catering Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8m |
| Lunch Catering Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1m |
| Lunch Catering Businessreportable segment | employees | at 2023-03-31 | 168 pure |
| Lunch Catering Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| Lunch Catering Businessreportable segment | segment assets | at 2023-03-31 | ¥720m |
| Lunch Catering Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥65m |
| Rental Facility Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥114m |
| Rental Facility Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥575m |
| Rental Facility Relatedreportable segment | employees | at 2023-03-31 | 134 pure |
| Rental Facility Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Rental Facility Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.6bn |
| Rental Facility Relatedreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥903m |
| Rental Facility Relatedreportable segment | segment assets | at 2023-03-31 | ¥16.8bn |
| Rental Facility Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥92m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥110.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥109.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥937m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥63.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥3m |
| Otherother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥0 |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥305m |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥305m |
| Otherother segments | segment assets | at 2022-03-31 | ¥62m |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥12m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥205m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥133m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥727m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥727m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥2.3bn |
| Community Pharmacy Network Segmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| Community Pharmacy Network Segmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥994m |
| Community Pharmacy Network Segmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥101.5bn |
| Community Pharmacy Network Segmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥101.5bn |
| Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥0 |
| Community Pharmacy Network Segmentreportable segment | segment assets | at 2022-03-31 | ¥43.0bn |
| Community Pharmacy Network Segmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥6.1bn |
| Lunch Catering Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥0 |
| Lunch Catering Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | segment assets | at 2022-03-31 | ¥699m |
| Lunch Catering Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1m |
| Rental Facility Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥181m |
| Rental Facility Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥598m |
| Rental Facility Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.3bn |
| Rental Facility Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Rental Facility Relatedreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥726m |
| Rental Facility Relatedreportable segment | segment assets | at 2022-03-31 | ¥17.5bn |
| Rental Facility Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥39m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥107.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥106.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥727m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥61.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥6.1bn |
| Otherother segments | employees | at 2023-03-31 | 38 pure |
| Community Pharmacy Network Segmentreportable segment | employees | at 2023-03-31 | 67 pure |
| Rental Facility Relatedreportable segment | employees | at 2023-03-31 | 115 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,584
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 31 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 26 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 25 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 41 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 42 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.934 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.784 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.293 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.026 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.791 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.950 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.859 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.221 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.246 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.318 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05274-000CommunityPharmacyNetworkSegmentReportableSegmentMember | 3145 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05274-000CommunityPharmacyNetworkSegmentReportableSegmentMember | 512 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05274-000RentalFacilityRelatedReportableSegmentsMember | 134 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05274-000RentalFacilityRelatedReportableSegmentsMember | 14 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05274-000LunchCateringBusinessReportableSegmentsMember | 168 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05274-000LunchCateringBusinessReportableSegmentsMember | 250 | |
| Number of employees | CurrentYearInstant_OtherReportableSegmentsMember | 38 | |
| Average number of temporary workers | CurrentYearInstant_OtherReportableSegmentsMember | 12 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 134 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 10 | |
| Number of employees | CurrentYearInstant | 3619 | |
| Average number of temporary workers | CurrentYearInstant | 798 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 354 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 42 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 42.1 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7.7 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5589000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05274-000CommunityPharmacyNetworkSegmentReportableSegmentMember | 67 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05274-000CommunityPharmacyNetworkSegmentReportableSegmentMember | 7 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05274-000RentalFacilityRelatedReportableSegmentsMember | 115 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05274-000RentalFacilityRelatedReportableSegmentsMember | 13 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_OtherReportableSegmentsMember | 38 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_OtherReportableSegmentsMember | 12 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 134 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 10 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 354 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 42 | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 4935000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05274-000CommunityPharmacyNetworkSegmentReportableSegmentMember | 4561000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05274-000RentalFacilityRelatedReportableSegmentsMember | 114000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05274-000FoodServiceReportableSegmentsMember | 8000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OtherReportableSegmentsMember | 2000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30642600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30642600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 30642600 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |